Literature DB >> 9074498

Plasmids for heterologous expression in Pasteurella haemolytica.

N D Fedorova1, S K Highlander.   

Abstract

New cloning and expression vectors that replicate both in Pasteurella haemolytica and in Escherichia coli were constructed based on a native sulfonamide (SuR) and streptomycin (SmR) resistant plasmid of P. haemolytica called pYFC1. Each shuttle vector includes an MCS and a selectable antibiotic resistance marker that is expressed in both organisms. Plasmid pNF2176 carries the P. haemolytica ROB-1 beta-lactamase gene (blaP, ApR) and pNF2214 carries the Tn903 aph3 kanamycin resistance (KmR) element. The expression vector, pNF2176, was created by placing the MCS downstream of the sulfonamide gene promoter (PsulII) on pYFC1; this was used to clone and express the promoterless Tn9 chloramphenicol resistance gene (cat, CmR) in P. haemolytica (pNF2200). A promoter-probe vector (pNF2283) was constructed from pNF2200 by deleting PsulII.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9074498     DOI: 10.1016/s0378-1119(96)00704-4

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  10 in total

1.  Construction of in-frame aroA deletion mutants of Mannheimia haemolytica, Pasteurella multocida, and Haemophilus somnus by using a new temperature-sensitive plasmid.

Authors:  Fred M Tatum; Robert E Briggs
Journal:  Appl Environ Microbiol       Date:  2005-11       Impact factor: 4.792

2.  The genome sequence of Mannheimia haemolytica A1: insights into virulence, natural competence, and Pasteurellaceae phylogeny.

Authors:  Jason Gioia; Xiang Qin; Huaiyang Jiang; Kenneth Clinkenbeard; Reggie Lo; Yamei Liu; George E Fox; Shailaja Yerrapragada; Michael P McLeod; Thomas Z McNeill; Lisa Hemphill; Erica Sodergren; Qiaoyan Wang; Donna M Muzny; Farah J Homsi; George M Weinstock; Sarah K Highlander
Journal:  J Bacteriol       Date:  2006-10       Impact factor: 3.490

3.  Inactivation of Pasteurella (Mannheimia) haemolytica leukotoxin causes partial attenuation of virulence in a calf challenge model.

Authors:  S K Highlander; N D Fedorova; D M Dusek; R Panciera; L E Alvarez; C Rinehart
Journal:  Infect Immun       Date:  2000-07       Impact factor: 3.441

4.  Generation of targeted nonpolar gene insertions and operon fusions in Pasteurella haemolytica and creation of a strain that produces and secretes inactive leukotoxin.

Authors:  N D Fedorova; S K Highlander
Journal:  Infect Immun       Date:  1997-07       Impact factor: 3.441

5.  Use of operon fusions in Mannheimia haemolytica to identify environmental and cis-acting regulators of leukotoxin transcription.

Authors:  A M Marciel; S K Highlander
Journal:  Infect Immun       Date:  2001-10       Impact factor: 3.441

6.  Construction and characterization of an acapsular mutant of Mannheimia haemolytica A1.

Authors:  Linda J McKerral; Reggie Y C Lo
Journal:  Infect Immun       Date:  2002-05       Impact factor: 3.441

7.  A putative leucine zipper activator of Pasteurella haemolytica leukotoxin transcription and the potential for modulation of its synthesis by slipped-strand mispairing.

Authors:  S K Highlander; V T Hang
Journal:  Infect Immun       Date:  1997-09       Impact factor: 3.441

8.  Analysis of the immunological responses to transferrin and lactoferrin receptor proteins from Moraxella catarrhalis.

Authors:  R H Yu; R A Bonnah; S Ainsworth; A B Schryvers
Journal:  Infect Immun       Date:  1999-08       Impact factor: 3.441

9.  Identification of novel glycosyltransferases required for assembly of the Pasteurella multocida A:1 lipopolysaccharide and their involvement in virulence.

Authors:  John D Boyce; Marina Harper; Frank St Michael; Marietta John; Annie Aubry; Henrietta Parnas; Susan M Logan; Ian W Wilkie; Mark Ford; Andrew D Cox; Ben Adler
Journal:  Infect Immun       Date:  2009-01-21       Impact factor: 3.441

10.  Immunogenicity of Pasteurella multocida and Mannheimia haemolytica outer membrane vesicles.

Authors:  Sandro Roier; Judith C Fenninger; Deborah R Leitner; Gerald N Rechberger; Joachim Reidl; Stefan Schild
Journal:  Int J Med Microbiol       Date:  2013-05-10       Impact factor: 3.473

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.